

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.35451927 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.24083271 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.18697297 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.18697297 |
| 5 | regulation of gamma-delta T cell activation (GO:0046643) | 5.17980574 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.84168735 |
| 7 | positive thymic T cell selection (GO:0045059) | 4.60672136 |
| 8 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.47712826 |
| 9 | response to interleukin-15 (GO:0070672) | 4.47470937 |
| 10 | interferon-gamma production (GO:0032609) | 4.44621723 |
| 11 | negative T cell selection (GO:0043383) | 4.42365964 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32463247 |
| 13 | negative thymic T cell selection (GO:0045060) | 4.30601891 |
| 14 | tolerance induction (GO:0002507) | 4.30414575 |
| 15 | T cell migration (GO:0072678) | 4.29377989 |
| 16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.27805880 |
| 17 | NIK/NF-kappaB signaling (GO:0038061) | 4.26534476 |
| 18 | positive T cell selection (GO:0043368) | 4.17638945 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 4.15838984 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 4.13680493 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.06256769 |
| 22 | response to type I interferon (GO:0034340) | 4.05248739 |
| 23 | type I interferon signaling pathway (GO:0060337) | 4.02947246 |
| 24 | cellular response to type I interferon (GO:0071357) | 4.02947246 |
| 25 | T cell selection (GO:0045058) | 3.96194352 |
| 26 | thymic T cell selection (GO:0045061) | 3.95112290 |
| 27 | response to peptidoglycan (GO:0032494) | 3.88419192 |
| 28 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.85309327 |
| 29 | response to muramyl dipeptide (GO:0032495) | 3.82685574 |
| 30 | negative regulation of cell killing (GO:0031342) | 3.73637243 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.73637243 |
| 32 | leukocyte aggregation (GO:0070486) | 3.73144994 |
| 33 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.64781160 |
| 34 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.61952042 |
| 35 | myeloid dendritic cell activation (GO:0001773) | 3.59934396 |
| 36 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.56285928 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.55497056 |
| 38 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.54208678 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.53791888 |
| 40 | macrophage activation involved in immune response (GO:0002281) | 3.52840533 |
| 41 | myeloid dendritic cell differentiation (GO:0043011) | 3.45482788 |
| 42 | regulation of chronic inflammatory response (GO:0002676) | 3.42304290 |
| 43 | positive regulation of B cell differentiation (GO:0045579) | 3.36436618 |
| 44 | B cell receptor signaling pathway (GO:0050853) | 3.34549154 |
| 45 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.33017492 |
| 46 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.31975048 |
| 47 | positive regulation of interleukin-2 production (GO:0032743) | 3.30356275 |
| 48 | detection of other organism (GO:0098543) | 3.29122180 |
| 49 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28707525 |
| 50 | detection of bacterium (GO:0016045) | 3.28250013 |
| 51 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.25275933 |
| 52 | defense response to protozoan (GO:0042832) | 3.23772579 |
| 53 | response to protozoan (GO:0001562) | 3.23254891 |
| 54 | negative regulation of T cell mediated immunity (GO:0002710) | 3.22453610 |
| 55 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.21433335 |
| 56 | regulation of B cell differentiation (GO:0045577) | 3.20457901 |
| 57 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.19227952 |
| 58 | regulation of response to interferon-gamma (GO:0060330) | 3.15108885 |
| 59 | germinal center formation (GO:0002467) | 3.14477884 |
| 60 | T cell receptor signaling pathway (GO:0050852) | 3.13347833 |
| 61 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.13009017 |
| 62 | positive regulation of isotype switching (GO:0045830) | 3.12807974 |
| 63 | negative regulation of innate immune response (GO:0045824) | 3.10993925 |
| 64 | neutrophil activation involved in immune response (GO:0002283) | 3.10524648 |
| 65 | regulation of T cell tolerance induction (GO:0002664) | 3.10117900 |
| 66 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.09980046 |
| 67 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.09621003 |
| 68 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.09437892 |
| 69 | regulation of interferon-alpha production (GO:0032647) | 3.08523694 |
| 70 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.07956623 |
| 71 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.07570099 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 3.06531443 |
| 73 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.06303475 |
| 74 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.06189409 |
| 75 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.05347090 |
| 76 | natural killer cell activation (GO:0030101) | 3.03875911 |
| 77 | mature B cell differentiation (GO:0002335) | 3.03569273 |
| 78 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.98204862 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 2.98171704 |
| 80 | positive regulation of humoral immune response (GO:0002922) | 2.96840853 |
| 81 | regulation of regulatory T cell differentiation (GO:0045589) | 2.96184441 |
| 82 | lymphocyte homeostasis (GO:0002260) | 2.94562792 |
| 83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92009139 |
| 84 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.91975700 |
| 85 | T cell homeostasis (GO:0043029) | 2.91252774 |
| 86 | lymphocyte migration (GO:0072676) | 2.90866228 |
| 87 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.90339460 |
| 88 | alpha-beta T cell activation (GO:0046631) | 2.90315984 |
| 89 | mast cell activation (GO:0045576) | 2.90290693 |
| 90 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.89378836 |
| 91 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.88599936 |
| 92 | T-helper cell differentiation (GO:0042093) | 2.88599936 |
| 93 | positive regulation of macrophage differentiation (GO:0045651) | 2.88359373 |
| 94 | regulation of tolerance induction (GO:0002643) | 2.87408055 |
| 95 | positive regulation of interferon-alpha production (GO:0032727) | 2.86487493 |
| 96 | positive regulation of DNA recombination (GO:0045911) | 2.86426399 |
| 97 | T-helper 1 type immune response (GO:0042088) | 2.85686381 |
| 98 | positive regulation by symbiont of host defense response (GO:0052509) | 2.84960848 |
| 99 | modulation by symbiont of host defense response (GO:0052031) | 2.84960848 |
| 100 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.84960848 |
| 101 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.84960848 |
| 102 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.84960848 |
| 103 | modulation by symbiont of host immune response (GO:0052553) | 2.84960848 |
| 104 | positive regulation of B cell activation (GO:0050871) | 2.84355663 |
| 105 | dendritic cell differentiation (GO:0097028) | 2.82676709 |
| 106 | B cell mediated immunity (GO:0019724) | 2.81919601 |
| 107 | mature B cell differentiation involved in immune response (GO:0002313) | 2.81262742 |
| 108 | neutrophil activation (GO:0042119) | 2.81234442 |
| 109 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.81057179 |
| 110 | cellular response to interferon-beta (GO:0035458) | 2.80953980 |
| 111 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.80880948 |
| 112 | T cell lineage commitment (GO:0002360) | 2.80736917 |
| 113 | positive regulation of B cell mediated immunity (GO:0002714) | 2.80686420 |
| 114 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.80686420 |
| 115 | natural killer cell differentiation (GO:0001779) | 2.79990856 |
| 116 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.79443134 |
| 117 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.78942420 |
| 118 | B cell homeostasis (GO:0001782) | 2.78550136 |
| 119 | regulation of interleukin-2 production (GO:0032663) | 2.78481036 |
| 120 | alpha-beta T cell differentiation (GO:0046632) | 2.78306207 |
| 121 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.78290379 |
| 122 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78290379 |
| 123 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.77816371 |
| 124 | lymphocyte chemotaxis (GO:0048247) | 2.77715315 |
| 125 | positive regulation of type 2 immune response (GO:0002830) | 2.75865677 |
| 126 | detection of external biotic stimulus (GO:0098581) | 2.75645085 |
| 127 | leukocyte cell-cell adhesion (GO:0007159) | 2.75040026 |
| 128 | T cell costimulation (GO:0031295) | 2.74599253 |
| 129 | positive regulation of antigen processing and presentation (GO:0002579) | 2.73854345 |
| 130 | myeloid cell activation involved in immune response (GO:0002275) | 2.73611744 |
| 131 | regulation of interleukin-12 production (GO:0032655) | 2.72601376 |
| 132 | T cell differentiation (GO:0030217) | 2.72538043 |
| 133 | T cell differentiation involved in immune response (GO:0002292) | 2.72517507 |
| 134 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.72517507 |
| 135 | regulation of RIG-I signaling pathway (GO:0039535) | 2.72239490 |
| 136 | JAK-STAT cascade (GO:0007259) | 2.70627647 |
| 137 | lymphocyte costimulation (GO:0031294) | 2.69769391 |
| 138 | positive regulation of B cell proliferation (GO:0030890) | 2.69420400 |
| 139 | cellular extravasation (GO:0045123) | 2.64524482 |
| 140 | regulation of alpha-beta T cell activation (GO:0046634) | 2.62159841 |
| 141 | lymph node development (GO:0048535) | 2.61775142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.91804727 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.52665818 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.51969364 |
| 4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.17613763 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.93280334 |
| 6 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.80966726 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.76740545 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.74178914 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.53826068 |
| 10 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.29955384 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.18092422 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13438490 |
| 13 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.12388233 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.99552725 |
| 15 | * MYB_26560356_Chip-Seq_TH2_Human | 2.86732765 |
| 16 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.86648768 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.84486790 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.80174432 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.76986701 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.76238596 |
| 21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.68031129 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.59236661 |
| 23 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55136861 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 2.48035627 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40868780 |
| 26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40589390 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.34670595 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.31628499 |
| 29 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.04435474 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04291725 |
| 31 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.92312405 |
| 32 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90752894 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89928763 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.89620655 |
| 35 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.85168288 |
| 36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.83120160 |
| 37 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80342539 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75872686 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69159416 |
| 40 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.68968070 |
| 41 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.68075516 |
| 42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.67587394 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63879091 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.62274953 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62037173 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.57154994 |
| 47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.55840493 |
| 48 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52608622 |
| 49 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50820993 |
| 50 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.44546859 |
| 51 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.39099514 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35759180 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34134027 |
| 54 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.33701416 |
| 55 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33627811 |
| 56 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.30484252 |
| 57 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.29530811 |
| 58 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28062207 |
| 59 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27341021 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24299509 |
| 61 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.22440454 |
| 62 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21071437 |
| 63 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16975957 |
| 64 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16709320 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16704156 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15893871 |
| 67 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15863917 |
| 68 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15109458 |
| 69 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14433035 |
| 70 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14070131 |
| 71 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13848131 |
| 72 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11874006 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09358694 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07700209 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07574813 |
| 76 | GATA3_26560356_Chip-Seq_TH2_Human | 1.06894276 |
| 77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.06846813 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04320790 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03022371 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03009805 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02763846 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02360164 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02079104 |
| 84 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00328337 |
| 85 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97588737 |
| 86 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97381149 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96143894 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91606921 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91266157 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89616913 |
| 91 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.89225747 |
| 92 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.87357540 |
| 93 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87334048 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 0.87157033 |
| 95 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.86127102 |
| 96 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.85698358 |
| 97 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.85698358 |
| 98 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84873140 |
| 99 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.84327128 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82920151 |
| 101 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.81801790 |
| 102 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.78769548 |
| 103 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.78599720 |
| 104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77640674 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.75425415 |
| 106 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.75417798 |
| 107 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73723798 |
| 108 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73284738 |
| 109 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72566198 |
| 110 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.72545886 |
| 111 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71748786 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.71353317 |
| 113 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70797003 |
| 114 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.67930985 |
| 115 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67374151 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67314016 |
| 117 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.63819742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 3.69116191 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.65256298 |
| 3 | MP0000685_abnormal_immune_system | 3.35487019 |
| 4 | MP0001790_abnormal_immune_system | 3.22668981 |
| 5 | MP0005387_immune_system_phenotype | 3.22668981 |
| 6 | MP0001800_abnormal_humoral_immune | 3.10746724 |
| 7 | MP0005671_abnormal_response_to | 3.01698968 |
| 8 | MP0003436_decreased_susceptibility_to | 2.95240585 |
| 9 | MP0009785_altered_susceptibility_to | 2.93468890 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.87080939 |
| 11 | MP0003724_increased_susceptibility_to | 2.77080253 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.69397715 |
| 13 | MP0004510_myositis | 2.69146320 |
| 14 | MP0002723_abnormal_immune_serum | 2.65914032 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.53748932 |
| 16 | MP0001819_abnormal_immune_cell | 2.51696849 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.49168173 |
| 18 | MP0005025_abnormal_response_to | 2.44808839 |
| 19 | MP0002166_altered_tumor_susceptibility | 2.37708131 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.36822241 |
| 21 | MP0002405_respiratory_system_inflammati | 2.35287776 |
| 22 | MP0002398_abnormal_bone_marrow | 2.30226875 |
| 23 | MP0001853_heart_inflammation | 2.28038032 |
| 24 | MP0003303_peritoneal_inflammation | 2.24483500 |
| 25 | MP0002419_abnormal_innate_immunity | 2.18805550 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.17506922 |
| 27 | MP0000716_abnormal_immune_system | 2.09541080 |
| 28 | MP0002006_tumorigenesis | 2.06208649 |
| 29 | MP0004947_skin_inflammation | 2.03952364 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 2.02525955 |
| 31 | MP0005058_abnormal_lysosome_morphology | 2.02472918 |
| 32 | MP0003300_gastrointestinal_ulcer | 1.97890769 |
| 33 | MP0009278_abnormal_bone_marrow | 1.89798015 |
| 34 | MP0000689_abnormal_spleen_morphology | 1.86548521 |
| 35 | MP0000703_abnormal_thymus_morphology | 1.86186425 |
| 36 | MP0001873_stomach_inflammation | 1.85781582 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.85537091 |
| 38 | MP0002722_abnormal_immune_system | 1.84593283 |
| 39 | MP0006082_CNS_inflammation | 1.83634221 |
| 40 | MP0009840_abnormal_foam_cell | 1.82392237 |
| 41 | MP0003866_abnormal_defecation | 1.78542483 |
| 42 | MP0002254_reproductive_system_inflammat | 1.75087043 |
| 43 | MP0005451_abnormal_body_composition | 1.72715980 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.69702048 |
| 45 | MP0002429_abnormal_blood_cell | 1.68469544 |
| 46 | MP0002933_joint_inflammation | 1.65578694 |
| 47 | MP0001845_abnormal_inflammatory_respons | 1.65321347 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.61891482 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.61891482 |
| 50 | MP0004381_abnormal_hair_follicle | 1.47314378 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.46164767 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.44508123 |
| 53 | MP0001851_eye_inflammation | 1.41515982 |
| 54 | MP0003828_pulmonary_edema | 1.40935396 |
| 55 | MP0003075_altered_response_to | 1.40087124 |
| 56 | MP0008007_abnormal_cellular_replicative | 1.36077290 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.34438241 |
| 58 | MP0005310_abnormal_salivary_gland | 1.33229024 |
| 59 | MP0003448_altered_tumor_morphology | 1.31410408 |
| 60 | MP0000858_altered_metastatic_potential | 1.22962273 |
| 61 | MP0000490_abnormal_crypts_of | 1.18459323 |
| 62 | MP0008260_abnormal_autophagy | 1.17660881 |
| 63 | MP0008004_abnormal_stomach_pH | 1.13900550 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.12421533 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.10294851 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.09028980 |
| 67 | MP0000604_amyloidosis | 1.08435973 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.08004260 |
| 69 | MP0008469_abnormal_protein_level | 1.02059535 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.01351161 |
| 71 | MP0008058_abnormal_DNA_repair | 1.00085023 |
| 72 | MP0008057_abnormal_DNA_replication | 0.93319051 |
| 73 | MP0009764_decreased_sensitivity_to | 0.93285433 |
| 74 | MP0002009_preneoplasia | 0.91931870 |
| 75 | MP0005390_skeleton_phenotype | 0.91103674 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.89990548 |
| 77 | MP0001663_abnormal_digestive_system | 0.88056692 |
| 78 | MP0005075_abnormal_melanosome_morpholog | 0.86939688 |
| 79 | MP0003045_fibrosis | 0.86822287 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 0.85874898 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.85370101 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.83849203 |
| 83 | MP0005167_abnormal_blood-brain_barrier | 0.82867526 |
| 84 | MP0002132_abnormal_respiratory_system | 0.82630754 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 0.82535782 |
| 86 | MP0005023_abnormal_wound_healing | 0.80254057 |
| 87 | MP0003786_premature_aging | 0.78764082 |
| 88 | MP0004883_abnormal_blood_vessel | 0.77862952 |
| 89 | MP0005076_abnormal_cell_differentiation | 0.76380735 |
| 90 | MP0005164_abnormal_response_to | 0.74638140 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.72861934 |
| 92 | MP0000343_altered_response_to | 0.71681489 |
| 93 | MP0002095_abnormal_skin_pigmentation | 0.70841017 |
| 94 | MP0001216_abnormal_epidermal_layer | 0.70132308 |
| 95 | MP0003690_abnormal_glial_cell | 0.70076208 |
| 96 | MP0003091_abnormal_cell_migration | 0.69079517 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.68311040 |
| 98 | MP0003279_aneurysm | 0.68239778 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.66866214 |
| 100 | MP0002139_abnormal_hepatobiliary_system | 0.66005034 |
| 101 | MP0010307_abnormal_tumor_latency | 0.65906819 |
| 102 | MP0001191_abnormal_skin_condition | 0.64621124 |
| 103 | MP0003943_abnormal_hepatobiliary_system | 0.64436883 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.63887883 |
| 105 | MP0008874_decreased_physiological_sensi | 0.63738955 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.63383000 |
| 107 | MP0000249_abnormal_blood_vessel | 0.63084600 |
| 108 | MP0003795_abnormal_bone_structure | 0.61260009 |
| 109 | MP0001348_abnormal_lacrimal_gland | 0.60777518 |
| 110 | MP0009763_increased_sensitivity_to | 0.59909669 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.59625069 |
| 112 | MP0000569_abnormal_digit_pigmentation | 0.59571163 |
| 113 | MP0003077_abnormal_cell_cycle | 0.59416737 |
| 114 | MP0001542_abnormal_bone_strength | 0.58364677 |
| 115 | MP0002060_abnormal_skin_morphology | 0.58292907 |
| 116 | MP0010094_abnormal_chromosome_stability | 0.58228315 |
| 117 | MP0008995_early_reproductive_senescence | 0.57224087 |
| 118 | MP0000609_abnormal_liver_physiology | 0.56172662 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.55358868 |
| 120 | MP0001879_abnormal_lymphatic_vessel | 0.54519696 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.53609255 |
| 122 | MP0005535_abnormal_body_temperature | 0.52404385 |
| 123 | MP0001243_abnormal_dermal_layer | 0.52057254 |
| 124 | MP0005381_digestive/alimentary_phenotyp | 0.51070487 |
| 125 | MP0000383_abnormal_hair_follicle | 0.50374015 |
| 126 | MP0005166_decreased_susceptibility_to | 0.49549771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.15347351 |
| 2 | Myositis (HP:0100614) | 4.65994343 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.42037998 |
| 4 | Recurrent fungal infections (HP:0002841) | 4.32986069 |
| 5 | Recurrent bronchitis (HP:0002837) | 4.32724960 |
| 6 | Stomatitis (HP:0010280) | 4.20963551 |
| 7 | T lymphocytopenia (HP:0005403) | 4.11330788 |
| 8 | Recurrent viral infections (HP:0004429) | 4.09894524 |
| 9 | Abnormality of T cell number (HP:0011839) | 4.09859243 |
| 10 | Chronic otitis media (HP:0000389) | 4.04431074 |
| 11 | IgM deficiency (HP:0002850) | 4.00506188 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.85824450 |
| 13 | Optic neuritis (HP:0100653) | 3.85824450 |
| 14 | Orchitis (HP:0100796) | 3.83404472 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.77365204 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.76546506 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.76546506 |
| 18 | Agammaglobulinemia (HP:0004432) | 3.73666258 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.68237080 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.66939373 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.62353977 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.62353977 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.62353977 |
| 24 | Abnormality of T cells (HP:0002843) | 3.55003744 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.46578515 |
| 26 | Abnormality of the fingertips (HP:0001211) | 3.45912843 |
| 27 | Meningitis (HP:0001287) | 3.39760950 |
| 28 | B lymphocytopenia (HP:0010976) | 3.37753058 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.37753058 |
| 30 | Cellulitis (HP:0100658) | 3.36999619 |
| 31 | Inflammation of the large intestine (HP:0002037) | 3.32757943 |
| 32 | Vasculitis (HP:0002633) | 3.31325556 |
| 33 | Recurrent bacterial skin infections (HP:0005406) | 3.27838568 |
| 34 | Eosinophilia (HP:0001880) | 3.27038092 |
| 35 | Chronic diarrhea (HP:0002028) | 3.20453674 |
| 36 | Nasal polyposis (HP:0100582) | 3.17711859 |
| 37 | Severe combined immunodeficiency (HP:0004430) | 3.15393357 |
| 38 | Thyroiditis (HP:0100646) | 3.14628013 |
| 39 | Gastrointestinal inflammation (HP:0004386) | 3.14162479 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 3.10523945 |
| 41 | Dysostosis multiplex (HP:0000943) | 3.09226635 |
| 42 | Increased IgE level (HP:0003212) | 3.05485432 |
| 43 | IgG deficiency (HP:0004315) | 3.03115117 |
| 44 | Chronic sinusitis (HP:0011109) | 3.01294836 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 3.00411966 |
| 46 | Pulmonary infiltrates (HP:0002113) | 2.99090604 |
| 47 | Autoimmune thrombocytopenia (HP:0001973) | 2.98201909 |
| 48 | Abnormality of eosinophils (HP:0001879) | 2.97958748 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.96079962 |
| 50 | Gastrointestinal infarctions (HP:0005244) | 2.95715679 |
| 51 | Abnormality of the nasal mucosa (HP:0000433) | 2.91144078 |
| 52 | Pustule (HP:0200039) | 2.88340180 |
| 53 | IgA deficiency (HP:0002720) | 2.86747118 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.84719463 |
| 55 | Leukocytosis (HP:0001974) | 2.84569128 |
| 56 | Recurrent skin infections (HP:0001581) | 2.84342799 |
| 57 | Colitis (HP:0002583) | 2.84006274 |
| 58 | Loss of speech (HP:0002371) | 2.83336958 |
| 59 | Granulocytopenia (HP:0001913) | 2.81349036 |
| 60 | Hemoptysis (HP:0002105) | 2.77833086 |
| 61 | Combined immunodeficiency (HP:0005387) | 2.73311852 |
| 62 | Lymphopenia (HP:0001888) | 2.68176026 |
| 63 | Keratoconjunctivitis sicca (HP:0001097) | 2.63805357 |
| 64 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.61961057 |
| 65 | Increased IgM level (HP:0003496) | 2.61274189 |
| 66 | Recurrent sinusitis (HP:0011108) | 2.59039470 |
| 67 | Vacuolated lymphocytes (HP:0001922) | 2.57147778 |
| 68 | Obstructive lung disease (HP:0006536) | 2.48915191 |
| 69 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48915191 |
| 70 | Keratoconjunctivitis (HP:0001096) | 2.48256685 |
| 71 | Thrombocytosis (HP:0001894) | 2.45969014 |
| 72 | Arterial thrombosis (HP:0004420) | 2.44352538 |
| 73 | Lymphoma (HP:0002665) | 2.42145829 |
| 74 | Urticaria (HP:0001025) | 2.41874740 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.41648023 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.41119329 |
| 77 | Osteomyelitis (HP:0002754) | 2.37918972 |
| 78 | Bronchitis (HP:0012387) | 2.33704475 |
| 79 | Cheilitis (HP:0100825) | 2.33053314 |
| 80 | Gangrene (HP:0100758) | 2.31954576 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.30165235 |
| 82 | Encephalitis (HP:0002383) | 2.29566018 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.28831333 |
| 84 | Gingivitis (HP:0000230) | 2.28281956 |
| 85 | Abnormality of macrophages (HP:0004311) | 2.26974728 |
| 86 | Gastrointestinal stroma tumor (HP:0100723) | 2.26307229 |
| 87 | Restrictive lung disease (HP:0002091) | 2.26148515 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.25907936 |
| 89 | Recurrent pneumonia (HP:0006532) | 2.25891221 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25089397 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25089397 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25089397 |
| 93 | Abnormality of the prostate (HP:0008775) | 2.24742125 |
| 94 | Hematochezia (HP:0002573) | 2.22836563 |
| 95 | Emphysema (HP:0002097) | 2.21943471 |
| 96 | Pulmonary embolism (HP:0002204) | 2.21262805 |
| 97 | Lip pit (HP:0100267) | 2.20639081 |
| 98 | Increased serum ferritin (HP:0003281) | 2.19809573 |
| 99 | Purpura (HP:0000979) | 2.18877623 |
| 100 | Prolonged bleeding time (HP:0003010) | 2.18396024 |
| 101 | Premature loss of primary teeth (HP:0006323) | 2.18364660 |
| 102 | Papilloma (HP:0012740) | 2.17654295 |
| 103 | Verrucae (HP:0200043) | 2.17654295 |
| 104 | Periodontitis (HP:0000704) | 2.14813759 |
| 105 | Skin ulcer (HP:0200042) | 2.13625035 |
| 106 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.11088444 |
| 107 | Mucopolysacchariduria (HP:0008155) | 2.08995460 |
| 108 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08995460 |
| 109 | Anorexia (HP:0002039) | 2.08887607 |
| 110 | Prostate neoplasm (HP:0100787) | 2.08192997 |
| 111 | Glomerulopathy (HP:0100820) | 2.06446889 |
| 112 | Persistence of primary teeth (HP:0006335) | 2.05502476 |
| 113 | Sepsis (HP:0100806) | 2.04359685 |
| 114 | Stomach cancer (HP:0012126) | 2.03870985 |
| 115 | Hepatosplenomegaly (HP:0001433) | 2.02293683 |
| 116 | Recurrent lower respiratory tract infections (HP:0002783) | 2.02085015 |
| 117 | Joint swelling (HP:0001386) | 2.01880463 |
| 118 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.93547204 |
| 119 | Epistaxis (HP:0000421) | 1.91570456 |
| 120 | Petechiae (HP:0000967) | 1.88209061 |
| 121 | Chest pain (HP:0100749) | 1.86189148 |
| 122 | Increased density of long bones (HP:0006392) | 1.84775801 |
| 123 | Gingival bleeding (HP:0000225) | 1.83350857 |
| 124 | Keratitis (HP:0000491) | 1.82810745 |
| 125 | Acute myeloid leukemia (HP:0004808) | 1.80910960 |
| 126 | Leukopenia (HP:0001882) | 1.78762100 |
| 127 | Arthralgia (HP:0002829) | 1.77506118 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.43379118 |
| 2 | TXK | 3.88382445 |
| 3 | PRPF4B | 3.46439293 |
| 4 | MAP3K14 | 3.37446302 |
| 5 | TYK2 | 2.94853026 |
| 6 | IKBKE | 2.75936489 |
| 7 | JAK3 | 2.71718658 |
| 8 | NLK | 2.65947397 |
| 9 | ITK | 2.35966216 |
| 10 | TEC | 2.26900159 |
| 11 | TBK1 | 2.23143053 |
| 12 | IRAK4 | 2.18382972 |
| 13 | JAK1 | 2.11515509 |
| 14 | EPHA3 | 2.10588593 |
| 15 | ZAP70 | 2.08810346 |
| 16 | IKBKB | 2.04361223 |
| 17 | FGFR4 | 2.03693901 |
| 18 | IRAK3 | 1.97849084 |
| 19 | MAP3K10 | 1.94944833 |
| 20 | STK10 | 1.90062730 |
| 21 | BTK | 1.86696068 |
| 22 | TAOK2 | 1.75737679 |
| 23 | EPHB1 | 1.70666446 |
| 24 | CHUK | 1.62431872 |
| 25 | SIK1 | 1.61206234 |
| 26 | MAP3K11 | 1.60632160 |
| 27 | EEF2K | 1.57452424 |
| 28 | GRK6 | 1.56884713 |
| 29 | FGFR3 | 1.52657178 |
| 30 | HCK | 1.52333502 |
| 31 | BLK | 1.48639593 |
| 32 | CDK12 | 1.48474520 |
| 33 | PIM1 | 1.48432311 |
| 34 | KIT | 1.42479812 |
| 35 | CLK1 | 1.41835776 |
| 36 | ERN1 | 1.41606455 |
| 37 | SYK | 1.40377372 |
| 38 | PIM2 | 1.40235065 |
| 39 | LCK | 1.39650340 |
| 40 | MST4 | 1.37670504 |
| 41 | TGFBR2 | 1.31356361 |
| 42 | TAOK1 | 1.30035194 |
| 43 | RPS6KA4 | 1.25231867 |
| 44 | TRIB3 | 1.22978015 |
| 45 | MAP2K3 | 1.20681510 |
| 46 | MATK | 1.18489881 |
| 47 | SIK3 | 1.17554246 |
| 48 | CSK | 1.16637599 |
| 49 | MARK3 | 1.11100558 |
| 50 | IRAK1 | 1.11074006 |
| 51 | MAP3K13 | 1.10914260 |
| 52 | SMG1 | 1.10761144 |
| 53 | GRK7 | 1.10429521 |
| 54 | MAP3K1 | 1.08123789 |
| 55 | CDC42BPA | 1.05915815 |
| 56 | FGR | 0.95632344 |
| 57 | HIPK2 | 0.95617019 |
| 58 | TGFBR1 | 0.95282682 |
| 59 | IRAK2 | 0.93651616 |
| 60 | TESK2 | 0.91628501 |
| 61 | CSF1R | 0.89684621 |
| 62 | MARK2 | 0.87549993 |
| 63 | ZAK | 0.85353099 |
| 64 | CAMKK1 | 0.83711174 |
| 65 | MAP2K2 | 0.83701731 |
| 66 | PASK | 0.83491653 |
| 67 | MAP3K3 | 0.82058015 |
| 68 | BRD4 | 0.81598655 |
| 69 | LYN | 0.81120636 |
| 70 | FES | 0.80392631 |
| 71 | RPS6KA5 | 0.79884894 |
| 72 | JAK2 | 0.74517020 |
| 73 | SIK2 | 0.74004022 |
| 74 | RIPK1 | 0.73847502 |
| 75 | CDK9 | 0.72032075 |
| 76 | RIPK4 | 0.71594052 |
| 77 | TAOK3 | 0.69653165 |
| 78 | STK4 | 0.69584892 |
| 79 | BMPR2 | 0.69463986 |
| 80 | TSSK6 | 0.67114694 |
| 81 | MOS | 0.66237111 |
| 82 | EIF2AK2 | 0.61376665 |
| 83 | RPS6KL1 | 0.61107201 |
| 84 | RPS6KC1 | 0.61107201 |
| 85 | TRPM7 | 0.60738905 |
| 86 | DDR2 | 0.60053409 |
| 87 | NME2 | 0.59477042 |
| 88 | PRKCQ | 0.59068299 |
| 89 | CAMKK2 | 0.55919664 |
| 90 | LRRK2 | 0.54710917 |
| 91 | PDK1 | 0.53778633 |
| 92 | NEK9 | 0.53344279 |
| 93 | FLT3 | 0.51607070 |
| 94 | MAPK7 | 0.51500057 |
| 95 | TYRO3 | 0.49100931 |
| 96 | MAPKAPK2 | 0.47688020 |
| 97 | MKNK2 | 0.46612868 |
| 98 | RPS6KB2 | 0.46127836 |
| 99 | KDR | 0.45925859 |
| 100 | STK24 | 0.45171737 |
| 101 | MAP2K6 | 0.44269368 |
| 102 | PTK6 | 0.42523091 |
| 103 | SGK3 | 0.42341133 |
| 104 | RPS6KA6 | 0.40783095 |
| 105 | MAPK4 | 0.39332905 |
| 106 | DYRK1B | 0.38389445 |
| 107 | ABL1 | 0.38382912 |
| 108 | CDK4 | 0.37261720 |
| 109 | TNK2 | 0.36649784 |
| 110 | MELK | 0.36154543 |
| 111 | SGK2 | 0.36062238 |
| 112 | PRKCH | 0.35693243 |
| 113 | RPS6KA2 | 0.35654098 |
| 114 | FYN | 0.35358862 |
| 115 | MAP3K5 | 0.35213256 |
| 116 | TLK1 | 0.34477309 |
| 117 | ICK | 0.33667828 |
| 118 | BMPR1B | 0.33351080 |
| 119 | RPS6KA1 | 0.33199462 |
| 120 | BMX | 0.32870942 |
| 121 | CDK6 | 0.32605851 |
| 122 | MAPK3 | 0.32352964 |
| 123 | MAP3K7 | 0.30203414 |
| 124 | EIF2AK3 | 0.29283301 |
| 125 | NUAK1 | 0.28855601 |
| 126 | MAPK15 | 0.27134559 |
| 127 | MAPK12 | 0.24853496 |
| 128 | ATR | 0.24378058 |
| 129 | CDK8 | 0.24311756 |
| 130 | MAPK11 | 0.23980847 |
| 131 | PDGFRB | 0.23000344 |
| 132 | PRKD2 | 0.22634116 |
| 133 | PKN1 | 0.22540292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.76485560 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.01461088 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.96170340 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65407787 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.61184866 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.37507382 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27006939 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.21483415 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.09159643 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.07165409 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.04873388 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.04605554 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.00939924 |
| 14 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.00003503 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87933103 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.86971724 |
| 17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.84967117 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.82550872 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.81847882 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79319912 |
| 21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.77312047 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.68938258 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.64518394 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.63565999 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.50622622 |
| 26 | Hepatitis B_Homo sapiens_hsa05161 | 1.42353954 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.39546146 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.38763522 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36124332 |
| 30 | Apoptosis_Homo sapiens_hsa04210 | 1.33901819 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.31902659 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.30879879 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25007027 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24294383 |
| 35 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.22799418 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.19740050 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.18260021 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.16370793 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15606255 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14775015 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.13458059 |
| 42 | HTLV-I infection_Homo sapiens_hsa05166 | 1.10783146 |
| 43 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07409813 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.05458903 |
| 45 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.04791892 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03339961 |
| 47 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01351015 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98910278 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96585820 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.90819534 |
| 51 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89590692 |
| 52 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.89509798 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88668467 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87596346 |
| 55 | Salmonella infection_Homo sapiens_hsa05132 | 0.86425026 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.85613673 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.83450366 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82770763 |
| 59 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.76829562 |
| 60 | Prion diseases_Homo sapiens_hsa05020 | 0.72256737 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72159892 |
| 62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71152317 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.70450062 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69892469 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69233432 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64235301 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62458265 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62267211 |
| 69 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59317661 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58562626 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57650723 |
| 72 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57464141 |
| 73 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56397894 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.55395515 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54596855 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53355296 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.50903909 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50580117 |
| 79 | DNA replication_Homo sapiens_hsa03030 | 0.50380891 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.48474057 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47834381 |
| 82 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47061489 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.45564453 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44538092 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.44374275 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42959881 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41444431 |
| 88 | Ribosome_Homo sapiens_hsa03010 | 0.41236296 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40405978 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.39971119 |
| 91 | Insulin resistance_Homo sapiens_hsa04931 | 0.38765851 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38526908 |
| 93 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38098471 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.37449455 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37335863 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.36206432 |
| 97 | RNA degradation_Homo sapiens_hsa03018 | 0.35949222 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35671460 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35600079 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35469329 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35367787 |
| 102 | Adherens junction_Homo sapiens_hsa04520 | 0.35241068 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35195207 |
| 104 | Spliceosome_Homo sapiens_hsa03040 | 0.35153463 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34900894 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30547850 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30049406 |
| 108 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29749488 |
| 109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29268549 |
| 110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28687881 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28517219 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28513069 |
| 113 | Mismatch repair_Homo sapiens_hsa03430 | 0.26988206 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.26075600 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.25316550 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25186487 |
| 117 | Focal adhesion_Homo sapiens_hsa04510 | 0.23493118 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.23198139 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.22745321 |
| 120 | Amoebiasis_Homo sapiens_hsa05146 | 0.22202482 |
| 121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20753627 |
| 122 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20676088 |

